http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111973733-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0e9df0e2bd4908785342fee723cf33 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate | 2020-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b05fd232b83af20db64eb23426fc0f |
| publicationDate | 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111973733-A |
| titleOfInvention | An anti-cancer immune boosting compound |
| abstract | The invention discloses an anti-cancer immune-enhancing compound, comprising the following mass ratios: 3.5-4.5 parts of nicotinamide mononucleotide, 3.5-4.5 parts of albumin peptide, 2.5-3.5 parts of dandelion root extract, yew extract 0.5-1.5 servings. In the present invention, the anti-cancer immune boosting compound contains nicotinamide mononucleotide, albumin peptide, dandelion root extract and yew extract, and nicotinamide mononucleotide can restore human DNA cell damage and activate human body The function of DNA cells, dandelion root extract has a strong anti-cancer and anti-cancer effect, which can fight free radicals, directly inhibit the growth of cancer cells and promote cancer. Metabolic function, through diuresis and defecation, the virus in the human body is removed from the body to prevent cancer; at the same time, it can inhibit the mitosis of cancer cells, thereby effectively preventing the growth of cancer cells, and has anti-leukemia and tumor effects. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023276167-A1 |
| priorityDate | 2020-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.